August 30, 2010:
Hologic To Present At The 2010 Morgan Stanley Global Healthcare Conference
Read Release

August 11, 2010 at 1:00pm Eastern:
Hologic Presents at the Canaccord Genuity 30th Annual Growth Conference 2010
Read Release
Listen to Live Webcast
 View Presentation

August 5, 2010
Hologic Completes Acquisition of Sentinelle Medical
Read Press Release

August 2, 2010:
Hologic Announces Third Quarter Fiscal 2010 Operating Results
Read Press Release
Listen to Replay of Webcast
 View Presentation

July 27, 2010
Hologic Announces Panel Date for its Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Read Release

June 23, 2010:
Hologic To Present At The 2010 Wells Fargo Securities Healthcare Conference in Boston
Listen to Replay of Webcast
 View Presentation

Welcome

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications.

Headquartered in Bedford, Massachusetts, Hologic employs approximately 4,000 employees worldwide. The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX" and included in the Nasdaq-100 Index.